Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $2.5 million.

  • Cryo Cell International's Free Cash Flow rose 1094.04% to $2.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was $6.2 million, marking a year-over-year increase of 10023.55%. This contributed to the annual value of $3.6 million for FY2024, which is 7335.77% up from last year.
  • Latest data reveals that Cryo Cell International reported Free Cash Flow of $2.5 million as of Q3 2025, which was up 1094.04% from $644606.0 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Free Cash Flow peaked at $2.7 million during Q1 2021, and registered a low of -$8.5 million during Q3 2022.
  • Moreover, its 5-year median value for Free Cash Flow was $1.3 million (2023), whereas its average is $643095.6.
  • Per our database at Business Quant, Cryo Cell International's Free Cash Flow crashed by 172011.02% in 2022 and then surged by 289134.99% in 2025.
  • Cryo Cell International's Free Cash Flow (Quarter) stood at $1.4 million in 2021, then soared by 76.92% to $2.5 million in 2022, then tumbled by 33.62% to $1.6 million in 2023, then soared by 31.87% to $2.1 million in 2024, then rose by 16.26% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $644606.0 for Q2 2025, and $892010.0 during Q1 2025.